Sysmex (OTCMKTS:SSMXY) Issues Earnings Results

Sysmex (OTCMKTS:SSMXYGet Free Report) announced its earnings results on Friday. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.04), MarketWatch Earnings reports. Sysmex had a net margin of 10.22% and a return on equity of 11.13%. The business had revenue of $770.84 million for the quarter.

Sysmex Stock Performance

Shares of Sysmex stock traded down $0.25 during trading hours on Friday, hitting $25.68. 26,287 shares of the company’s stock traded hands, compared to its average volume of 31,731. Sysmex has a 12-month low of $22.18 and a 12-month high of $36.57. The stock has a market capitalization of $10.77 billion, a price-to-earnings ratio of 34.24 and a beta of 0.68. The company has a fifty day simple moving average of $27.40 and a 200-day simple moving average of $26.71. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.97 and a quick ratio of 2.19.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Further Reading

Earnings History for Sysmex (OTCMKTS:SSMXY)

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with's FREE daily email newsletter.